Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 27,185 shares at $5.85 ($161K) on 2021-11-10, disclosed to the SEC on 2021-11-12.
Open-market purchase of $161k STSA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.85 | 9,622 | $56K | 35.0% |
| 2 | $5.85 | 9,622 | $56K | 35.0% |
| 3 | $6.05 | 7,941 | $48K | 29.9% |
| Total | $5.91 avg | 27,185 | $161K | 100% |
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |